(Q40580607)

21 September 2017

title

Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets (English)

1 reference

21 September 2017

Herlocher ML

1

1 reference

21 September 2017

Carr J

2

1 reference

21 September 2017

Ives J

3

1 reference

21 September 2017

Elias S

4

1 reference

21 September 2017

Truscon R

5

1 reference

21 September 2017

Roberts N

6

1 reference

21 September 2017

Monto AS

7

1 reference

21 September 2017

publication date

1 May 2002

1 reference

21 September 2017

1 reference

21 September 2017

volume

54

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

99-111

1 reference

Role of surface glycoproteins in influenza virus pyrogenicity

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

Ferrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

Evaluation of a cold-recombinant influenza virus vaccine in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

Aspects of virulence in ferrets exhibited by influenza virus recombinants of known genetic constitution

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

Resistance of influenza viruses to neuraminidase inhibitors--a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

Assessment of signs of influenza illness in the ferret model

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

Lessons for human influenza from pathogenicity studies with ferrets

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

Free contact infection in ferret groups

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

1 reference

7 January 2021

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900214-5

7 January 2021

10.1016/S0166-3542(01)00214-5

Identifiers

DOI

1 reference

21 September 2017

1 reference